Search Results

Containing any of the words

Only of the type

CAMBRIA-2: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) as Adjuvant Treatment for Patients with ER+/HER2- Early Breast Cancer and an Intermediate-High or High Risk of Recurrence Who Have Completed Definitive Locoregional Treatment and Have No Evidence of Disease Drug Clinical Trial

A Randomized, Multi-Center Study to Evaluate Cardiovascular Outcomes With ITCA 650 in Patients Treated With Standard of Care for Type 2 Diabetes Drug Clinical Trial

"A Randomized, Multi-Center Study to Evaluate Cardiovascular Outcomes With ITCA 650 in Patients Treated With Standard of Care for Type 2 Diabetes " Drug Clinical Trial

"SFDA" Alerts about a Defect in "hoffrichter” GmbH, Breathing Devices Cables Warnings

His Excellency, Executive President of the SFDA, Welcomed a Delegation of the GCC Standardization Organization News

SFDA President: We are working on supporting private sector by creating flexible and easy systems News

(Lenalidomide SPC® (lenalidomide Risk Minimization Activity

Requirements on Importation and Shipments Clearance of Medical Devices (MDS-REQ5) Regulations

Recommendations for Healthcare Providers regarding the safe use of the Injectable Dermal Filler Medical Report

Post-Market Clinical Evaluation Study for the Safety and Effectiveness of Inhaled Nitric Oxide Therapy Medical devices studies